JMJD5 promotes chemotherapy sensitivity of cisplatin in NSCLC by enhancing DNA damage

Jing He, Haohao Wei, Tao Li, Qiuxiang Xiao, Guiling Liu

Open source

DOI
10.1016/j.bbrc.2026.154270
Published
2026-09
Container
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bbrc.2026.154270,
  title = {JMJD5 promotes chemotherapy sensitivity of cisplatin in NSCLC by enhancing DNA damage},
  author = {Jing He and Haohao Wei and Tao Li and Qiuxiang Xiao and Guiling Liu},
  year = {2026},
  journal = {Biochemical and Biophysical Research Communications},
  doi = {10.1016/j.bbrc.2026.154270},
  url = {https://doi.org/10.1016/j.bbrc.2026.154270}
}

RIS

TY  - JOUR
TI  - JMJD5 promotes chemotherapy sensitivity of cisplatin in NSCLC by enhancing DNA damage
AU  - Jing He
AU  - Haohao Wei
AU  - Tao Li
AU  - Qiuxiang Xiao
AU  - Guiling Liu
PY  - 2026
JO  - Biochemical and Biophysical Research Communications
DO  - 10.1016/j.bbrc.2026.154270
UR  - https://doi.org/10.1016/j.bbrc.2026.154270
ER  - 

APA

He, J., Wei, H., Li, T., Xiao, Q., & Liu, G. (2026). JMJD5 promotes chemotherapy sensitivity of cisplatin in NSCLC by enhancing DNA damage. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2026.154270

Source records